T hyroid hormone has various effects on the cardiovascular system. L-Thyroxine (T4), the major secretory product of the thyroid gland is inactive. Thyroxine 5Ј-deiodinase converts T4 to an active hormone, 3,3Ј,5-triiodo-L-thyronine (T3). 1 T3 binds to thyroid hormone receptor that belongs to the nuclear receptor family. The activated thyroid hormone receptor induces gene expression through binding to thyroid hormone response element (TRE) in the promoter region of target genes. 2 An increase in left ventricular contractility, tachycardia, and reduction of systemic vascular resistance induce high cardiac output state in hyperthyroidism. The positive inotropic and chronotropic action of T3 are direct effects of T3 on cardiac myocytes, and T3 activates many gene expressions such as myosin heavy chain and calcium transport/regulatory proteins in myocytes. [3] [4] [5] Reduction of systemic vascular resistance is also a direct effect of T3 on vascular smooth muscle cells (VSMCs). 6 -8 A recent report showed that T3 caused rapid relaxation of VSMCs, suggesting the presence of rapid nongenomic effect of T3. 9 It was also shown that T3-induced relaxation of VSMCs was not mediated by cAMP or NO. The target genes for T3 action in VSMCs, which are involved in vascular relaxation, have not been determined.
Two isoforms for angiotensin (Ang) II receptor designated type 1 receptor (AT 1 R) 10 and type 2 receptor (AT 2 R) 11 are present. AT 1 R is a G protein-coupled receptor expressed in various tissues, including blood vessel, kidney, adrenal gland, liver, and reproductive organs. AT 1 R mediates most of the biological effects of Ang II such as vasoconstriction, water and sodium retention, and cell growth and proliferation, which are traditionally ascribed to the action of Ang II. 12, 13 Activation of AT 1 R has been also implicated in the pathogenesis of cardiovascular diseases. To date, the role of vascular AT 1 R in hyperthyroid state has not been reported. We examined whether T3 modulates expression level of AT 1 R.
Methods

Materials
Dulbecco's modified Eagle's medium was purchased from GIBCO BRL. Fetal bovine serum was purchased from BioWittaker. T3, T4, BSA, ionomycin, and actinomycin D were purchased from Sigma Chemical Co. Rabbit polyclonal antibodies against AT 1 
Cell Culture
VSMCs were isolated, maintained, and used for the experiments as described previously. 14 
Animals
All procedures and care were approved by the Committee on Ethics of Animal Experiments, Kyushu University, and were conducted according to animal care guidelines of the American Physiological Society. Adult male, 9-to 10-week-old Sprague-Dawley rats (300 to 400 g) were acclimated to a cycle of 12-hour light and 12-hour dark, and temperature was controlled. Rats received intraperitoneal injection of T3 (200 g/100 g body weight suspended in 0.02 N NaOH) every other day for 10 days (hyperthyroid group). The control group received an injection of 0.02 N NaOH. Systolic blood pressure and heart rate were measured using a tail-cuff method (UR-5000, UEDA). Plasma concentrations of T3, T4, and thyroid stimulating hormone (TSH) were measured by radioimmunoassay. Rats were killed under pentobarbital anesthesia. Aortas were quickly removed and stored at Ϫ80°C.
Northern Blot Analysis
Preparation of total RNA and Northern blot analysis for AT 1 R and 18S rRNA were performed as described previously. 15 To analyze mRNA stability of AT 1 R, actinomycin D (5 mg/mL) was added after 5 hours of stimulation with T3 (1 mol/L). VSMCs were harvested at 3, 6, 12, and 24 hours after addition of actinomycin D. The expression level of AT 1 R mRNA was examined by Northern blot analysis.
Western Blot Analysis of Rat Aorta
Aortas were minced into small pieces and homogenized on ice in a buffer (0.25 mol/L sucrose, 5 mmol/L Tris-HCl at pH7.5, 1 mmol/L MgCl 2 ). The homogenates were centrifuged at 2000 rpm for 15 minutes at 4°C, and the supernatants were centrifuged at 100 000g for 30 minutes at 4°C. The pellets were used as membrane fraction and subjected to Western blot analysis of AT 1 and actin as described previously. 16 
Estimation of AT 1 R Number
Measurement of AT 1 R Gene Promoter Activity
Promoter activity of AT 1 R gene was measured by luciferase assay and normalized by ␤-galactosidase activity as described previously. 16 
Measurement of Intracellular Calcium Response
To examine the fast effect, VSMCs were incubated in Dulbecco's modified Eagle's medium containing Fura-2/AM (5 mol/L) at 37°C for 1 hour and then treated with vehicle or T3 for 10 minutes. Then VSMCs were stimulated with Ang II, and [Ca 2ϩ ] i was measured with a fluorescence spectrophotometer (CAM-230, Japan Spectroscopy) as previously described. 18 To examine the slow effect of T3, VSMCs were treated with vehicle or T3 for 8 hours and then incubated with Fura-2/AM for 1 hour. VSMCs were stimulated with Ang II, and [Ca 2ϩ ] i was measured by the same method. The fluorescence data were expressed as percentages, with the values at rest and at the peak response obtained with 25 mmol/L ionomycin assigned to be 0% and 100%, respectively.
Quantitative Reverse Transcription-Polymerase Chain Reaction
The isolated aortas were homogenized, and total RNA was prepared according to an acid guanidinium thiocyanate-phenol-chloroform extraction method. Total RNA was treated with DNAse I and subjected to phenol-chloroform extraction and ethanol precipitation. Then, the total RNA (1 g) was reverse-transcribed using ReverTra Ace-␣ kit (TOYOBO). Real-time quantitative polymerase chain reaction (PCR) was performed with an ABI Prism 7700 sequence detection system (Applied Biosystems) according to the manufacturer's instruction. The sequences for sense and antisense of AT 1 R primers were 5Ј-CACAGTGTGCGCGTTTCATT-3Ј and 5Ј-TTGGTAAGGCCCAGCCCTAT-3Ј, respectively. Specific fluorescent probe 5Ј-TGAGTCTCGGAATTCGACGCTCCC-3Ј was labeled at the 5Ј end with the reporter FAM and at the 3Ј end with the quencher TAMRA. We used GAPDH primers and TaqMan Probe kit (Applied Biosystems). GAPDH probe was labeled at the 5Ј end with the reporter VIC and at the 3Ј end with the quencher TAMRA.
Statistical Analysis
Statistical analysis was performed with 1-way ANOVA and Fisher test, if appropriate. Mann-Whitney U test compared the difference of K d and AT 1 R site (B max ). Degradation of AT 1 R mRNA was analyzed by 2-way ANOVA. Data are shown as meanϮSEM. PϽ0.05 was considered to be statistically significant.
Results
Downregulation of AT 1 R mRNA Expression by T3
VSMCs were incubated with T3 (1 mol/L) for varying time periods, and expression level of AT 1 R mRNA was determined by Northern blot analysis. The expression level of AT 1 R mRNA was significantly reduced by T3 after 6 hours of stimulation ( Figure 1A ). Incubation with varying concentra- Ϫ8 to 10 Ϫ5 mol/L for 6 hours (nϭ4). Total RNA was isolated, and the expression of AT 1 R mRNA and 18S rRNA was determined by Northern blot analysis. The radioactivity of the AT 1 R mRNA bands was counted by a Bioimage Analyzer (Fuji Film) and was normalized with the radioactivity of rRNA. A representative autoradiography is displayed. The values (meanϮSEM) are expressed as a percent of control culture (100%). **PϽ0.01.
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tions of T3 for 6 hours resulted in a dose-dependent decrease in AT 1 R mRNA expression level ( Figure 1B ). To examine whether T3-induced downregulation of AT 1 R mRNA requires de novo protein synthesis, we next examined the effect of cycloheximide (10 g/mL). Incubation with cycloheximide alone for 6 hours slightly upregulated AT 1 R mRNA expression. T3 reduced AT 1 R mRNA level in the presence of cycloheximide (Figure 2A ), suggesting that de novo protein synthesis is not required for T3-induced AT 1 R downregulation. T4 also downregulated AT 1 R mRNA expression ( Figure 2B ), suggesting that T4 is locally converted to T3 by iodothyronine deiodinase in VSMCs.
T3-Induced AT 1 R Downregulation Is Not Mediated by NO
We previously reported that NO donor inhibited AT 1 R expression in VSMCs. 15 To examine whether NO mediates downregulation of AT 1 R by T3, we examined the effect of N G -nitro-L-arginine methyl ester (L-NAME), an inhibitor of NO synthase. T3 reduced AT 1 R mRNA level in the presence of 1 mmol/L of L-NAME (data not shown), suggesting that NO does not mediate T3-induced AT 1 R downregulation.
Corepressor Complex Is Not Involved in T3-Induced AT 1 R Downregulation
Thyroid hormone receptor forms a corepressor complex, which includes nuclear corepressor (N-CoR) or its functional homologue, silencing mediator for retinoid and thyroid receptors (SMRT), Sin3, and histone deacetylase (HDAC).
Recently, the N-CoR/SMRT corepressor complexes were shown to interact with various transcription factors and suppress target gene expression. 19, 20 We examined the effect of trichostatin A, an inhibitor for HDAC. T3 downregulated AT 1 R mRNA in the presence of trichostatin A, suggesting that the corepressor complex including HDAC is not involved in T3-induced AT 1 R downregulation in VSMCs (data not shown).
T3 Decreases the AT 1 R Density
To examine whether T3 downregulates AT 1 R number, radio ligand-binding assays were conducted (Figure 3 ). We examined binding activity, AT 1 R gene promoter activity, and calcium response to Ang II after 6, 9, 12, and 24 hours of T3 stimulation. We found that peak effect of T3 was at 9 hours of stimulation (data not shown 
Suppression of AT 1 R Expression by T3 Through Transcriptional and Posttranscriptional Mechanisms
To examine whether T3 suppresses AT 1 R promoter activity, AT 1 R promoter-luciferase fusion DNA construct was introduced into VSMCs. Then the VSMCs were stimulated with T3 (1 mol/L) for 9 hours. AT 1 R promoter activity measured by luciferase assay was reduced by 50% ( Figure 4A ), suggesting that T3 suppresses AT 1 R gene expression at the transcriptional level. We next examined whether T3 affects AT 1 R mRNA stability. In vehicle-treated cells, AT 1 R mRNA levels were reduced by 50% after 12 hours ( Figure 4B ). T3 destabilized AT 1 R mRNA, resulting in an AT 1 R mRNA half-life of 6 hours. These data suggest that T3 downregulates AT 1 R mRNA expression at both transcriptional and posttranscriptional levels.
T3 Decreases Functional Response of VSMCs to Angiotensin II
We examined whether downregulation of AT 1 
T3 Downregulates AT 1 R Expression in Rat Aorta
The physiological characteristics of control and hyperthyroid rats are shown in the Table. Heart rate of T3-treated rats was significantly increased (PϽ0.01). Body weight of T3-treated rats was not increased during the treatment and was signifi- cantly smaller (PϽ0.05) compared with that of control group after 10 days. Blood pressure of T3-treated rats was not changed, suggesting that increased cardiac output may compensate for decreased vascular resistance in this model. Plasma level of T3 was increased, whereas plasma level of T4 and TSH was significantly decreased in T3-treated rats, confirming that exogenous T3 sufficiently suppressed endogenous thyroid hormone system. We performed real-time quantitative reverse transcription-PCR. T3 reduced expression level of AT 1 R mRNA in rat aorta by 50% ( Figure 6A ). Western blot analysis of the aorta also showed that expression level of AT 1 R protein was reduced by T3 ( Figure 6B ).
Physiological Characteristics and Serum Hormone Concentration
Discussion
In the present study, we demonstrated that T3 downregulates AT 1 R mRNA expression at both transcriptional and posttranscriptional levels (Figure 4) . Downregulation of AT 1 R by T3 was demonstrated both in cultured VSMCs and rat aorta (Figures 1 and 6) . Binding assay showed a decrease in AT 1 R density without an alteration of the affinity to Ang II ( Figure  3 ). Downregulation of AT 1 R attenuated Ang II-induced [Ca 2ϩ ] i response ( Figure 5 ). Although regulation of cardiac Ang II receptor in hyperthyroid state has been reported, 21, 22 to our knowledge this is the first report showing the downregulation of vascular AT 1 R by T3.
Mizuma et al 8 have shown the presence of an iodothyronine deiodinase in human VSMCs. This suggests that VSMCs are able to convert T4 to T3. We showed that T4 suppressed AT 1 R mRNA expression. This suggests that rat VSMCs may have deiodinase activity as reported in human VSMCs. Ojamaa et al 9 reported that T3 caused rapid relaxation of VSMCs, suggesting the presence of rapid nongenomic mechanisms for the action of T3. T3-induced relaxation of VSMCs was not mediated by cAMP or NO. 9 It was also shown that phosphorylation of myosin light chain was not altered by T3. 9 Downregulation of AT 1 R occurred after several hours of T3-stimulation, indicating that the suppression is a genomic effect of T3. Because 10-minute incubation with T3 did not affect calcium response, it is unlikely that T3 directly inhibits calcium response to Ang II. The attenuated calcium response to Ang II after 9-hour treatment with T3 may reflect the reduced AT 1 R number. Therefore, both genomic and nongenomic effect of T3 may be involved in the reduction of vascular resistance in hyperthyroid state. Although the mechanism of T3-induced vascular relaxation is still elusive, thyroid hormone affect gene expression in blood vessel.
Four types of thyroid hormone receptor isoform are expressed in human VSMCs, as well as in rat VSMCs. 1, 8, 23 Although the target genes for T3 in VSMCs are incompletely characterized, it is generally accepted that T3-activated thyroid hormone receptor binds to TRE site of the promoter region of target genes and enhances gene transcription. 2 However, there are several genes that are suppressed by T3. The downregulation of gene expression by T3 is mediated by N-CoR and its functional homologue SMRT. In the absence of T3, thyroid hormone receptor recruits corepressor complex including N-CoR/SMRT, Sin3, and HDAC, and suppresses the transcription of target genes of T3. When T3 binds to thyroid hormone receptor, the corepressor complex inhibiting target gene expression is released. The released corepressor complex binds to other transcription factors such as Octamer transcription factor-1 (Oct-1) 19 and nuclear factor-B, 20 and inhibits the Oct-1-or nuclear factor-B-dependent gene transcription. Trichostatin A, an inhibitor of HDAC, is reported to restore SMRT-induced suppression of interleukin-2 gene expression, which is activated by nuclear factor-B. They also demonstrated that SMRT suppresses thymidine kinase gene expression, which is mediated by AP-1. In our result, however, T3 downregulated AT 1 R mRNA in the presence of trichostatin A, suggesting that corepressor complex including HDAC is not involved in T3-induced AT 1 R downregulation. Further study is necessary to determine the mechanisms for T3-induced AT 1 R downregulation.
Although there is a contradicting result, 9 a recent report showed that vascular endothelium is a target of thyroid hormone, and an excessive endothelial NO production plays a role in vasodilation in hyperthyroidism. 24 We previously reported that NO donor inhibited AT 1 R expression in VSMCs. 15 Therefore, it may be possible that T3 indirectly inhibits vascular AT 1 R expression through production of NO in addition to direct downregulation of AT 1 R. However, direct activation of NO synthase of VSMCs by T3 is unlikely because L-NAME, an inhibitor of NO synthase, did not affect T3-induced AT 1 R downregulation in VSMCs.
Recent reports examined the relationship between progression of atherosclerosis and thyroid function in patients with stable angina. 25, 26 It was shown that more angiographic progression of coronary atherosclerosis was observed in patients with lower serum T3 level after 2 years. This suggests that thyroid hormone may be protective against atherosclerosis. It is also reported that Ang II plays a critical Figure 6 . Effect of T3 on AT 1 R mRNA and protein expression in rat aorta. A, Total RNA from rat aorta was prepared and treated with DNAse I. Total RNA (1g) was reverse-transcribed. Quantitative PCR using the specific fluorescent probe of AT 1 R and GAPDH was performed. The values (meanϮSEM) are expressed as a percentage of control group (100%). nϭ6; *PϽ0.05 vs control. B, Membrane fractions of rat aorta were separated and analyzed with Western blot analysis using AT 1 R antibody and actin antibody. Density of the specific band was scanned and quantified with an imaging analyzer. The ratio of AT 1 R to actin is shown. The values (meanϮSEM) are expressed as a percentage of control group (100%). nϭ3; *PϽ0.05 vs control.
role in atherosclerotic vascular disease. [27] [28] [29] Our results suggest that antiatherosclerotic effect of T3 may involve downregulation of AT 1 R.
Perspectives
In summary, we showed in the present study that thyroid hormone downregulates AT 1 R expression at both transcriptional and posttranscriptional levels, and attenuates biological function of Ang II. Although further study is necessary to determine whether AT 1 R downregulation is involved in reduced vascular resistance in patients with hyperthyroidism, our data suggest that thyroid hormone may be a negative regulator of the renin-angiotensin system. The effect of thyroid hormone on cardiovascular system may be reevaluated in relation to the renin-angiotensin system in future.
